✨
AI Summary
- Ken Song discusses T-cell engagers for autoimmune diseases.
- Candid Therapeutics develops bispecific antibodies for autoimmune conditions.
- Focus on harnessing T-cells to treat immune system disorders.
Guests on This Episode
KS
Ken Song
2 podcast appearances